Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Mar 14, 2019 8:00pm
80 Views
Post# 29488515

RE:RE:RE:RE:RE:RE:RE:Good news may be. Coming soon

RE:RE:RE:RE:RE:RE:RE:Good news may be. Coming soon
Bunge wrote:
robertshaw wrote:
robertshaw wrote:
Bunge wrote:
robertshaw wrote:
Bunge wrote:
goregil wrote: Did you notice just before opening there was a huge bids at 53 cents and within seconds they were pulled.My opinion is that the exchanges are always on the look out for those trading on inside information.they may have determined that this was the case with the high bidders and pulled their bids
I may be totally wrong but Iam trying to make sense of this action


My little voice telling me news after close or 7am tomorrow.

Wish TLT would master the HALT approach to good news but they never have.


I bought in another 4k this morning.


You’re an animal robert.

Bone-in ribeye at Boa’s in Vegas on YOU.

Matter of fact, you’ll be paying for all the meals. :P


 


No worries. My treat.


Hi, buddy, just watch for ATOS, It just got FDA's permission to carry on human trials on breast cancer (safe to proceed...), then price shoot up nearly 400% Our glory days are coming on our way... I see Vegas this year...


Wow.

7.07 5.56  368.21%

Yep, that’s the dream in biotechs.

200,000 would be a Million bucks in one day...

Bring it.

Little difference in share count though... :P


Today's news was just FDA approval for ATOS to safe on proceed on human trials, nothing special. When we get FDA approval we'll be better than that. I had that guy on Iggy, so no bother.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities